Global Label-free Detection (LFD) Market 2017-2021 - Product Image

Global Label-free Detection (LFD) Market 2017-2021

  • ID: 4403348
  • Report
  • Region: Global
  • 76 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AMETEK
  • Attana
  • BiOptix
  • Bio-Rad Laboratories
  • Corning
  • F.Hoffman-La Roche
  • MORE
About Label-free Detection (LFD)

LFD technology is used in the process of drug discovery. The main use of LFD technology is kinetics and analysis during drug discovery. LFD technology is widely used for end-point screening and specificity testing. Some of the benefits of LFD technology include faster turnaround time, real-time kinetic analysis, and others. LFD technology has replaced radioactive assay and enzyme-linked immunosorbent assay (ELISA). It helps study the interaction between drug and target.

The analysts forecast the global label-free detection (LFD) market to grow at a CAGR of 10.76% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global label-free detection (LFD) market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Label-free Detection (LFD) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
  • Bio-Rad Laboratories
  • GE Healthcare
  • F.Hoffman-La Roche
Other prominent vendors
  • AMETEK
  • Attana
  • BiOptix
  • Corning
  • Juno Therapeutics
  • Pall
  • SymCel
Market drivers
  • Rise in drug discovery programs
  • For a full, detailed list, view the full report
Market challenges
  • Strained laboratory budgets and decline in reimbursement
  • For a full, detailed list, view the full report
Market trends
  • Potential opportunities for POL
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AMETEK
  • Attana
  • BiOptix
  • Bio-Rad Laboratories
  • Corning
  • F.Hoffman-La Roche
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Market overview
  • Biochemical assays
  • Cell-based assays
PART 07: Market segmentation by end-user
  • Market overview
PART 08: Geographical segmentation
  • Market overview
  • Americas
  • EMEA
  • APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Potential opportunities for POL
  • Advances in technology
PART 12: Vendor landscape
  • Competitive analysis
PART 13: Key vendor analysis
  • Bio-Rad Laboratories
  • GE Healthcare
  • F. Hoffman-La Roche
  • Key company to watch
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global LFD market 2016-2021: Overview
Exhibit 02: Global LFD market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global LFD market by product 2016-2021: Overview
Exhibit 05: Global biochemical assays market 2016-2021 ($ billions)
Exhibit 06: Impact assessment for global biochemical assays market 2016-2021
Exhibit 07: Global cell-based assays market 2016-2021 ($ billions)
Exhibit 08: Impact assessment for global cell-based assays market 2016-2021
Exhibit 09: Global LFD by end-user 2016-2021: Overview
Exhibit 10: Global LFD market segmentation by end-user 2016
Exhibit 11: Impact assessment of global LFD market 2016-2021
Exhibit 12: Global LFD market by geography 2016-2021: Overview
Exhibit 13: LFD market in Americas 2016-2021: Overview
Exhibit 14: LFD market in Americas 2016-2021 ($ billions)
Exhibit 15: LFD market in Americas: Future outlook
Exhibit 16: Americas: Market metrics in various countries
Exhibit 17: LFD market in EMEA 2016-2021: Overview
Exhibit 18: LFD market in EMEA 2016-2021 ($ billions)
Exhibit 19: EMEA: Market metrics in various countries
Exhibit 20: LFD market in EMEA: Future outlook
Exhibit 21: LFD market in APAC 2016-2021: Overview
Exhibit 22: LFD market in APAC 2016-2021 ($ billions)
Exhibit 23: APAC: Market metrics in various countries
Exhibit 24: LFD market in APAC: Future outlook
Exhibit 25: Competitive structure analysis of global LFD market 2016
Exhibit 26: Competitive analysis of global LFD market 2016
Exhibit 27: Strategic success factors of companies in global LFD market
Exhibit 28: Bio-Rad Laboratories: Key highlights
Exhibit 29: Bio-Rad Laboratories: Strength assessment
Exhibit 30: Bio-Rad Laboratories: Strategy assessment
Exhibit 31: Bio-Rad Laboratories: Opportunity assessment
Exhibit 32: GE Healthcare: Key highlights
Exhibit 33: GE Healthcare: Strength assessment
Exhibit 34: GE Healthcare: Strategy assessment
Exhibit 35: GE Healthcare: Opportunity assessment
Exhibit 36: F. Hoffmann-La Roche: Key highlights
Exhibit 37: F. Hoffmann-La Roche: Strength assessment
Exhibit 38: F. Hoffmann-La Roche: Strategy assessment
Exhibit 39: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 40: PerkinElmer: Company analysis
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AMETEK
  • Attana
  • BiOptix
  • Bio-Rad Laboratories
  • Corning
  • F.Hoffman-La Roche
  • MORE
New Report Released: – Global Label-free Detection (LFD) Market 2017-2021

The author of the report recognizes the following companies as the key players in the global label-free detection (LFD) market: Bio-Rad Laboratories, GE Healthcare, and F.Hoffman-La Roche.

Other Prominent Vendors in the market are: AMETEK, Attana, BiOptix, Corning, Juno Therapeutics, Pall, and SymCel.

Commenting on the report, an analyst from the research team said: “One trend in the market is potential opportunities for POL. Across the globe, there is neither uniformity nor support for the use of decentralized IVD tests in primary healthcare and outpatient settings. These tests are often performed in POL. The payers, regulators, and administrators are required to address the importance of POL testing as there are technical advances in portable IVD instruments.”

According to the report, one driver in the market is rise in drug discovery programs. The increasing incidence of chronic diseases such as respiratory diseases, chronic kidney diseases, leukemia, and others have contributed to the rise in drug discovery. Various drug discovery programs organized by many academic and research institutes across the world. The drug development helps in testing the toxicity of drug and efficacy at the target tissue or organ in a patient. Rise in drug discovery results in an increased demand for personalized medicines in the market. The market also witnesses an increase in partnership between academic research institutes and major pharmaceutical/ biotechnology companies.

Further, the report states that one challenge in the market is strained laboratory budgets and decline in reimbursement. The reimbursement policies for diagnostic testing are not constant across different geographies and they are moving in downward trend. The hospitals and diagnostic laboratories that are the primary end-user group are forced to reduce their expenditure on in-vitro diagnostic (IVD) instruments to have either break even or profitable revenue. There are workforce shortages at clinical laboratories and frequent visits to the doctor by patients who have lost their health insurance cards. These conditions have forced clinical laboratories to find alternative ways to maintain revenue despite limited capacity and testing volumes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Bio-Rad Laboratories
  • GE Healthcare
  • F.Hoffman-La Roche
  • AMETEK
  • Attana
  • BiOptix
  • Corning
  • Juno Therapeutics
  • Pall
  • SymCel
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll